Gambichler, T.; Lee, Y.-P.; Barras, M.; Scheel, C.H.; Susok, L.
Hyperpigmented Scleroderma-like Lesions under Combined Pembrolizumab and Pemetrexed Treatment of Non-Small Lung Cancer. Dermato 2022, 2, 8-13.
https://doi.org/10.3390/dermato2010002
AMA Style
Gambichler T, Lee Y-P, Barras M, Scheel CH, Susok L.
Hyperpigmented Scleroderma-like Lesions under Combined Pembrolizumab and Pemetrexed Treatment of Non-Small Lung Cancer. Dermato. 2022; 2(1):8-13.
https://doi.org/10.3390/dermato2010002
Chicago/Turabian Style
Gambichler, Thilo, Yi-Pei Lee, Milan Barras, Christina H. Scheel, and Laura Susok.
2022. "Hyperpigmented Scleroderma-like Lesions under Combined Pembrolizumab and Pemetrexed Treatment of Non-Small Lung Cancer" Dermato 2, no. 1: 8-13.
https://doi.org/10.3390/dermato2010002
APA Style
Gambichler, T., Lee, Y.-P., Barras, M., Scheel, C. H., & Susok, L.
(2022). Hyperpigmented Scleroderma-like Lesions under Combined Pembrolizumab and Pemetrexed Treatment of Non-Small Lung Cancer. Dermato, 2(1), 8-13.
https://doi.org/10.3390/dermato2010002